-
Mashup Score: 1Integrating imaging modalities for early detection of key microscopic abnormalities in diabetic retinopathy - 4 hour(s) ago
Ophthalmology Times – ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 0Adverum Biotechnologies announces topline 52-week results from LUNA Phase 2 trial and 4-year OPTIC results - 8 hour(s) ago
Both LUNA and OPTIC were designed to assess a broad wet AMD population, including hard-to-treat patients with severe disease who required frequent anti-VEGF injections before enrolling in the trial.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
Adverum Biotechnologies, Inc. announced topline 52-week results from the LUNA Phase 2 trial, new 4-year OPTIC long-term follow-up data, and key pivotal program design elements. https://t.co/eeTNMitSyy
-
-
Mashup Score: 0AlloVir and Kalaris Therapeutics announce all-stock merger to focus on retinal diseases - 12 hour(s) ago
After closing, the combined company is expected to operate under the name Kalaris Therapeutics, Inc.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
AlloVir, Inc. has entered into a definitive merger agreement to combine with Kalaris Therapeutics in an all-stock transaction. Under the terms of the agreement, AlloVir will acquire 100% of the outstanding equity interest of Kalaris. https://t.co/Vn2tSB0avT
-
-
Mashup Score: 0Avant Technologies and Ainnova Tech partner to advance retinal camera with AI-driven diagnostic platform - 17 hour(s) ago
Avant Technologies and Ainnova Tech have partnered to develop a low-cost retinal camera integrated with Ainnova’s Vision AI platform for early detection of ocular and systemic diseases. The technology will be marketed as a SaaS platform for primary care settings.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
Avant Technologies Inc. and its partner, Ainnova Tech Inc., have announced a collaboration to advance Ainnova’s proprietary low-cost retinal camera, designed for fundus photography. https://t.co/gClRcjyvzK
-
-
Mashup Score: 0SpyGlass Pharma completes enrollment in Phase I/II study of its long-term drug delivery platform for glaucoma and ocular hypertension - 21 hour(s) ago
SpyGlass Pharma completed enrollment in a Phase 1/2 trial evaluating its drug delivery platform for glaucoma and ocular hypertension. Designed for implantation during cataract surgery, the platform delivers bimatoprost to lower intraocular pressure for up to 3 years.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
SpyGlass Pharma announced completion of enrollment in its Phase I/II, randomized, multi-center, controlled clinical trial (NCT06120842) evaluating SpyGlass’ drug delivery platform in patients with glaucoma or ocular hypertension. https://t.co/8SGEmw9AaZ
-
-
Mashup Score: 1Recent changes to cornea: Preferred Practice Patterns - 1 day(s) ago
A Q&A with PPP Committee Cornea/External Disease Panel member Daniel S. Choi, MD.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
Ophthalmology Times conducted a Q&A interview with Daniel S. Choi, MD, a member of the Cornea/External Disease Panel of the PPP Committee, to discuss key revisions, including the acknowledgment of dry eye syndrome in younger patients and more https://t.co/4S4nMo7xWS https://t.co/xczXV5gD8W
-
-
Mashup Score: 1Integrating imaging modalities for early detection of key microscopic abnormalities in diabetic retinopathy - 1 day(s) ago
Ophthalmology Times – ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
A study led by Marie Elise Wistrup Torm, MD, reveals that combining noninvasive imaging techniques can detect microscopic abnormalities in diabetic retinopathy (DR) earlier and with greater detail than traditional fundus imaging. https://t.co/rMJOeouCNq https://t.co/HwTaOymDhv
-
-
Mashup Score: 0Adverum Biotechnologies announces topline 52-week results from LUNA Phase 2 trial and 4-year OPTIC results - 2 day(s) ago
Both LUNA and OPTIC were designed to assess a broad wet AMD population, including hard-to-treat patients with severe disease who required frequent anti-VEGF injections before enrolling in the trial.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
Adverum Biotechnologies, Inc. announced topline 52-week results from the LUNA Phase 2 trial, new 4-year OPTIC long-term follow-up data, and key pivotal program design elements. https://t.co/eeTNMitSyy
-
-
Mashup Score: 0AlloVir and Kalaris Therapeutics announce all-stock merger to focus on retinal diseases - 2 day(s) ago
After closing, the combined company is expected to operate under the name Kalaris Therapeutics, Inc.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
AlloVir, Inc. has entered into a definitive merger agreement to combine with Kalaris Therapeutics in an all-stock transaction. Under the terms of the agreement, AlloVir will acquire 100% of the outstanding equity interest of Kalaris. https://t.co/Vn2tSB0avT
-
-
Mashup Score: 2Innovation and the clinician-scientist - 2 day(s) ago
A discussion with Shigeru Kinoshita, MD, PhD; and Edward J. Holland, MD.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
Two pioneering clinician-scientists specializing in the cornea share their insights on the origins of their innovations, the journey to realization, and the essence of being a clinician-scientist. Read More: https://t.co/ZmV8FbqQMl https://t.co/FjGT8QWGrl
-
A study led by Marie Elise Wistrup Torm, MD, reveals that combining noninvasive imaging techniques can detect microscopic abnormalities in diabetic retinopathy (DR) earlier and with greater detail than traditional fundus imaging. https://t.co/rMJOeouCNq https://t.co/HwTaOymDhv